VALIANT LABORATORIES
|
The Current P/E Ratio of VALIANT LABORATORIES is 3,673.59.
Share Price | ₹85.9 | Sep 17,2025 |
Market Cap | ₹466.5 Cr | |
Earnings-TTM | ₹0.1 Cr | TTM-Consolidated Results |
Price/Earnings | 3,673.59x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VALIANT LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹466.5 Cr] as on Sep 17,2025
(/) Earnings [ ₹0.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 3,673.59x ]
Thus, for VALIANT LABORATORIES , the investors are currently willing to pay 3,673.59 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VALIANT LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VALIANT LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VALIANT LABORATORIES
PE Ratio Performance Analysis for VALIANT LABORATORIES
- VALIANT LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 612.41x.
- VALIANT LABORATORIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, VALIANT LABORATORIES 's p/e ratio peaked in Mar2024 at 1837.23x.
- VALIANT LABORATORIES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does VALIANT LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VALIANT LABORATORIES | 0.13 | 3,673.59 | 466.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.34 | 388,752.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 69.66 | 160,626.0 |
CIPLA LTD | 5,406.81 | 23.29 | 125,951.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 59.91 | 119,932.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 19.11 | 109,414.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.64 | 106,025.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.45 | 104,130.0 |
LUPIN LTD | 3,722.18 | 24.92 | 92,773.7 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.63 | 63,670.4 |
ABBOTT INDIA LTD | 1,452.29 | 45.28 | 65,762.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VALIANT LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 3.00x |
Max industry PE | 69.66x |
Median industry PE | 24.92x |
Average industry PE | 34.48x |
You may also like the below Video Courses